1,529 Shares in The Clorox Company (NYSE:CLX) Purchased by Security Financial Services INC.

Security Financial Services INC. purchased a new stake in The Clorox Company (NYSE:CLXFree Report) in the 1st quarter, HoldingsChannel.com reports. The fund purchased 1,529 shares of the company’s stock, valued at approximately $234,000.

Several other large investors have also recently added to or reduced their stakes in the company. Choreo LLC lifted its position in shares of Clorox by 12.8% during the 4th quarter. Choreo LLC now owns 5,741 shares of the company’s stock worth $819,000 after buying an additional 652 shares during the period. abrdn plc grew its stake in Clorox by 20.1% in the fourth quarter. abrdn plc now owns 198,250 shares of the company’s stock valued at $28,268,000 after acquiring an additional 33,135 shares during the period. Savoir Faire Capital Management L.P. grew its stake in Clorox by 61.8% in the fourth quarter. Savoir Faire Capital Management L.P. now owns 65,192 shares of the company’s stock valued at $9,296,000 after acquiring an additional 24,897 shares during the period. Banque Cantonale Vaudoise grew its stake in Clorox by 78.2% in the first quarter. Banque Cantonale Vaudoise now owns 29,335 shares of the company’s stock valued at $4,492,000 after acquiring an additional 12,872 shares during the period. Finally, International Assets Investment Management LLC boosted its position in shares of Clorox by 17,658.5% during the fourth quarter. International Assets Investment Management LLC now owns 484,453 shares of the company’s stock worth $69,078,000 after buying an additional 481,725 shares during the period. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Stock Performance

Shares of Clorox stock traded up $0.01 on Monday, hitting $136.65. The stock had a trading volume of 63,257 shares, compared to its average volume of 1,255,935. The stock has a market cap of $16.97 billion, a price-to-earnings ratio of 70.80, a price-to-earnings-growth ratio of 2.18 and a beta of 0.39. The Clorox Company has a twelve month low of $114.68 and a twelve month high of $169.14. The company has a quick ratio of 0.53, a current ratio of 0.90 and a debt-to-equity ratio of 9.73. The business’s 50 day moving average is $137.62 and its two-hundred day moving average is $144.03.

Clorox (NYSE:CLXGet Free Report) last announced its quarterly earnings results on Tuesday, April 30th. The company reported $1.71 EPS for the quarter, beating analysts’ consensus estimates of $1.33 by $0.38. The company had revenue of $1.81 billion during the quarter, compared to analysts’ expectations of $1.87 billion. Clorox had a return on equity of 302.49% and a net margin of 3.33%. Clorox’s revenue was down 5.3% compared to the same quarter last year. During the same period in the prior year, the company earned $1.51 EPS. Analysts forecast that The Clorox Company will post 5.91 EPS for the current year.

Analysts Set New Price Targets

Several research analysts have recently weighed in on CLX shares. Argus raised Clorox to a “hold” rating in a research report on Tuesday, June 4th. Wells Fargo & Company dropped their target price on Clorox from $140.00 to $135.00 and set an “underweight” rating on the stock in a report on Thursday, May 2nd. Morgan Stanley reiterated an “equal weight” rating and set a $160.00 target price on shares of Clorox in a report on Tuesday, March 26th. Citigroup dropped their target price on Clorox from $155.00 to $150.00 and set a “neutral” rating on the stock in a report on Wednesday, May 1st. Finally, The Goldman Sachs Group started coverage on Clorox in a report on Friday, March 1st. They set a “sell” rating and a $140.00 target price on the stock. Five analysts have rated the stock with a sell rating and fourteen have assigned a hold rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $145.33.

Check Out Our Latest Report on CLX

Clorox Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Further Reading

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.